AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31172821 — intervention group
Group type: COMPARATOR
Intervention: Normal saline applied after fractional CO2 laser (Control)
Number of subjects: 15
Study 31172821 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) applied after fractional CO2 laser (Control)
Number of subjects: 15
Study 29996243 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support status assessment using social support revalued scale and general questionnaire.
Number of subjects: 0
Study 27459523 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD4901 80 mg/day
Number of subjects: 67
Study 27459523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 24899360 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulphate (200 mg capsules containing 65 mg of iron), taken at mealtimes twice daily for one week.
Number of subjects: 20
Study 24899360 — intervention group
Group type: COMPARATOR
Intervention: Placebo, taken at mealtimes twice daily for one week.
Number of subjects: 20
Study 24899360 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulphate (200 mg capsules containing 65 mg of iron), during the wash-out week.
Number of subjects: 20
Study 24899360 — intervention group
Group type: COMPARATOR
Intervention: Placebo, during the wash-out week.
Number of subjects: 20
Study 24899360 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulphate vs. placebo for specific symptoms (heartburn, abdominal pain, black stools).
Number of subjects: 20
Study 23176731 — intervention group
Group type: EXPERIMENTAL
Intervention: High flux HD with exercise
Number of subjects: 15
Study 23176731 — intervention group
Group type: COMPARATOR
Intervention: Post-dilution HDF
Number of subjects: 15
Study 23176731 — intervention group
Group type: COMPARATOR
Intervention: High flux HD
Number of subjects: 15
Study 20304503 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine Extended Release (ER) for Two Years
Number of subjects: 1047
Study 19029275 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide (50 mg/kg for 4 days)
Number of subjects: 0
Study 19029275 — intervention group
Group type: COMPARATOR
Intervention: Monthly intravenous cyclophosphamide (750 mg/m²)
Number of subjects: 0
Study 19029275 — intervention group
Group type: EXPERIMENTAL
Intervention: Both cyclophosphamide regimens
Number of subjects: 0
Study 16102627 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic sympathectomy (VTS) at T2 ganglion
Number of subjects: 60
Study 16102627 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic sympathectomy (VTS) at T3 ganglion
Number of subjects: 60
Study 12412870 — intervention group
Group type: COMPARATOR
Intervention: Standard preterm formula without long-chain polyunsaturated fatty acids
Number of subjects: 42
Study 12412870 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula supplemented with docosahexaenoic acid (0.015 g/100 ml) and arachidonic acid (0.031 g/100 ml)
Number of subjects: 42
Study 10873425 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 8
Study 10873425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 8884648 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic toothbrush
Number of subjects: 40
Study 8884648 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 40
Study 1857534 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (CaCO3)
Number of subjects: 11
Study 1857534 — intervention group
Group type: COMPARATOR
Intervention: Aluminium hydroxide (Al(OH)3)
Number of subjects: 11
Study 6218927 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine 20 mg/kg in children
Number of subjects: 149
Study 6218927 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine 30 mg/kg in children
Number of subjects: 149
Study 6218927 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine 750 mg in adults
Number of subjects: 149
Study 6218927 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine 1000 mg in adults
Number of subjects: 149
Study 6218927 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine (any dose)
Number of subjects: 149
Study 31859138 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 2275
Study 31859138 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 2275
Study 31438906 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse‐Family Partnership, a home visitation program
Number of subjects: 739
Study 26076757 — intervention group
Group type: EXPERIMENTAL
Intervention: Laggera pterodonta mixture
Number of subjects: 133
Study 26076757 — intervention group
Group type: COMPARATOR
Intervention: Control mixture
Number of subjects: 133
Study 26112176 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 ppm F plus 1% TMP
Number of subjects: 10
Study 26112176 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,100 ppm F
Number of subjects: 10
Study 26112176 — intervention group
Group type: COMPARATOR
Intervention: 500 ppm F
Number of subjects: 10
Study 23731922 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary nicorandil (4 mg)
Number of subjects: 81
Study 23731922 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nicorandil)
Number of subjects: 81
Study 21570554 — intervention group
Group type: EXPERIMENTAL
Intervention: Condoms
Number of subjects: 4905
Study 21570554 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectables
Number of subjects: 4905
Study 21570554 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Contraceptives (OC)
Number of subjects: 4905
Study 21570554 — intervention group
Group type: COMPARATOR
Intervention: Condoms plus diaphragm
Number of subjects: 4905
Study 19235749 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted learning (CAL)
Number of subjects: 47
Study 19235749 — intervention group
Group type: COMPARATOR
Intervention: Text-based learning
Number of subjects: 47
Study 16810141 — intervention group
Group type: EXPERIMENTAL
Intervention: Allon Thermowrap system
Number of subjects: 100
Study 16810141 — intervention group
Group type: COMPARATOR
Intervention: Conventional temperature management method
Number of subjects: 100
Study 12394847 — intervention group
Group type: EXPERIMENTAL
Intervention: Gengraf
Number of subjects: 50
Study 12394847 — intervention group
Group type: COMPARATOR
Intervention: Neoral
Number of subjects: 50
Study 10550135 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (250 mg/m²) as 24-hour infusion
Number of subjects: 174
Study 10550135 — intervention group
Group type: COMPARATOR
Intervention: FAC (fluorouracil, doxorubicin, and cyclophosphamide in standard doses at every-3-week intervals)
Number of subjects: 174
Study 7845867 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemo-endocrine therapy (orchiectomy and/or diethylstilbestrol diphosphate (DES-DP) plus Cisplatin, with or without other cytotoxic agents)
Number of subjects: 129
Study 7845867 — intervention group
Group type: COMPARATOR
Intervention: Endocrine therapy alone
Number of subjects: 129
Study 2104073 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate 120 mg q.d.s.
Number of subjects: 60
Study 2104073 — intervention group
Group type: COMPARATOR
Intervention: Colloidal bismuth subcitrate 240 mg b.d.
Number of subjects: 60
Study 350052 — intervention group
Group type: EXPERIMENTAL
Intervention: mepivacaine 2% with hyaluronidase
Number of subjects: 27
Study 350052 — intervention group
Group type: COMPARATOR
Intervention: mepivacaine 2% alone
Number of subjects: 27
Study 7043713 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluproquazone
Number of subjects: 170
Study 7043713 — intervention group
Group type: COMPARATOR
Intervention: Dextropropoxyphene hydrochloride-paracetamol (Cosalgesic)
Number of subjects: 170
Study 31254481 — intervention group
Group type: EXPERIMENTAL
Intervention: icosapent ethyl (a purified and stabilized ethyl ester of EPA)
Number of subjects: 0
Study 29224040 — intervention group
Group type: EXPERIMENTAL
Intervention: cTBS (continuous theta burst stimulation)
Number of subjects: 86
Study 29224040 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 86
Study 26866296 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based deliberate practice
Number of subjects: 28
Study 26866296 — intervention group
Group type: COMPARATOR
Intervention: Self-guided practice
Number of subjects: 28
Study 24180699 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 5 mg/kg
Number of subjects: 9
Study 24180699 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 10 mg/kg
Number of subjects: 9
Study 22946957 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised psycho-education focusing on behaviours prior to and during illness-related crisis, distribution of a crisis card, and 24-month preventive monitoring of individual risk factors for compulsory re-admission.
Number of subjects: 200
Study 22946957 — intervention group
Group type: COMPARATOR
Intervention: Standard care procedures (control group).
Number of subjects: 200
Study 22946957 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised psycho-education and monitoring.
Number of subjects: 200
Study 19933175 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 50 mg kg(‐1) for 15 min and then 15 mg kg(‐1) h(‐1) by continuous i.v. infusion until the end of surgery
Number of subjects: 40
Study 19933175 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline over the same period
Number of subjects: 40
Study 17565435 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg melatonin
Number of subjects: 24
Study 17565435 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg dronabinol
Number of subjects: 24
Study 17565435 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 16245488 — intervention group
Group type: EXPERIMENTAL
Intervention: Study stimulus consisting of 1 to 4 curved contours presented briefly followed by a single contour stimulus after a retention interval.
Number of subjects: 0
Study 16245488 — intervention group
Group type: EXPERIMENTAL
Intervention: Study stimuli always consisted of 4 items, with varying numbers of memorised items in each condition.
Number of subjects: 0
Study 16245488 — intervention group
Group type: EXPERIMENTAL
Intervention: Study stimuli with set size 4 compared to set size 1.
Number of subjects: 0
Study 11818760 — intervention group
Group type: EXPERIMENTAL
Intervention: P6 Acupuncture
Number of subjects: 120
Study 11818760 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 120
Study 11818760 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 120
Study 10450298 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH dietary intervention
Number of subjects: 0
Study 7484482 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium bromide (OTB)
Number of subjects: 12
Study 7484482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2187615 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial-containing varnish (with chlorhexidine and thymol)
Number of subjects: 10
Study 2187615 — intervention group
Group type: COMPARATOR
Intervention: Control varnish (no active ingredients)
Number of subjects: 10
Study 7393998 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose Fluphenazine-Decanoate (average dose 225 mg in 14 days)
Number of subjects: 40
Study 7393998 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose Fluphenazine-Decanoate (25 mg in 14 days)
Number of subjects: 40
Study 7393998 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose Fluphenazine-Decanoate
Number of subjects: 40
Study 7393998 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose Fluphenazine-Decanoate
Number of subjects: 40
Study 31127468 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated consent model (ICM) with oral consent
Number of subjects: 2000
Study 31127468 — intervention group
Group type: COMPARATOR
Intervention: Standard of care interventions (including surgical, adjuvant chemotherapy, supportive care, radiology, vascular devices, palliative care, molecular diagnostics)
Number of subjects: 2000
Study 28943492 — intervention group
Group type: EXPERIMENTAL
Intervention: PPH plus single‐purse suture (Group A)
Number of subjects: 90
Study 28943492 — intervention group
Group type: COMPARATOR
Intervention: PPH plus multipoint umbrella suture (Group B)
Number of subjects: 90
Study 26033220 — intervention group
Group type: EXPERIMENTAL
Intervention: neoadjuvant axitinib therapy
Number of subjects: 22
Study 23663409 — intervention group
Group type: EXPERIMENTAL
Intervention: Spoken presentation of negative training
Number of subjects: 94
Study 23663409 — intervention group
Group type: COMPARATOR
Intervention: Written presentation of negative training
Number of subjects: 94
Study 23663409 — intervention group
Group type: EXPERIMENTAL
Intervention: Spoken presentation of benign training
Number of subjects: 94
Study 23663409 — intervention group
Group type: COMPARATOR
Intervention: Written presentation of benign training
Number of subjects: 94
Study 22264208 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% Alendronate (ALN) gel
Number of subjects: 70
Study 22264208 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 70
Study 19129280 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol
Number of subjects: 15
Study 19129280 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol alone
Number of subjects: 15
Study 19129280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 17472820 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 to 10 mg + Valsartan 160 mg
Number of subjects: 130
Study 17472820 — intervention group
Group type: COMPARATOR
Intervention: Lisinopril 10 to 20 mg + HCTZ 12.5 mg
Number of subjects: 130
Study 15262126 — intervention group
Group type: EXPERIMENTAL
Intervention: CMC regimen (carboplatin 1500 mg/m², mitoxantrone 75 mg/m², cyclophosphamide 120 mg/kg)
Number of subjects: 67
Study 15262126 — intervention group
Group type: COMPARATOR
Intervention: CTC regimen (cisplatin 165 mg/m², thiotepa 600 mg/m², cyclophosphamide 5625 mg/m²)
Number of subjects: 67
Study 11827498 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic spinal manipulation
Number of subjects: 0
Study 10682563 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol plus routine therapy
Number of subjects: 43
Study 10682563 — intervention group
Group type: COMPARATOR
Intervention: Routine therapy only
Number of subjects: 43
Study 8565696 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminoglutethimide (AG)
Number of subjects: 39
Study 8565696 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyprogesterone caproate
Number of subjects: 39
Study 8565696 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of AG and hydroxyprogesterone caproate
Number of subjects: 39
Study 2474097 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril or Enalapril (ACE inhibitors) for 2-6 months
Number of subjects: 12
Study 2474097 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril or Enalapril combined with Mepitiostane (antiestrogenic steroid)
Number of subjects: 12
Study 105098 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole therapy
Number of subjects: 48
Study 105098 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 31274602 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 15 mg/kg
Number of subjects: 45
Study 31274602 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 45
Study 31274602 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 45
Study 31274602 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 30845265 — intervention group
Group type: EXPERIMENTAL
Intervention: LMS method of standardisation for language measures
Number of subjects: 0
Study 30845265 — intervention group
Group type: EXPERIMENTAL
Intervention: Online calculator for estimating standardised scores
Number of subjects: 0
Study 28555508 — intervention group
Group type: COMPARATOR
Intervention: Conventional 120‐kVp scan with a CM volume of 70 ml and an injection rate of 5 ml s‐1 (Group A)
Number of subjects: 120
Study 28555508 — intervention group
Group type: EXPERIMENTAL
Intervention: ssDECT scan with CM volume of 0.6 ml/kg and 40% ASIR (Group B)
Number of subjects: 120
Study 28555508 — intervention group
Group type: EXPERIMENTAL
Intervention: ssDECT scan with CM volume of 0.4 ml/kg and 50% ASIR (Group C)
Number of subjects: 120
Study 26692559 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal periarticular anaesthetic infiltration
Number of subjects: 264
Study 26692559 — intervention group
Group type: COMPARATOR
Intervention: Femoral nerve anaesthetic blockade
Number of subjects: 264
Study 23764765 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-open approach (MO-TLIF)
Number of subjects: 41
Study 23764765 — intervention group
Group type: COMPARATOR
Intervention: Classic open approach (CL-TLIF)
Number of subjects: 41
Study 21693058 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia teaching method for ankle/foot examination techniques
Number of subjects: 45
Study 21693058 — intervention group
Group type: COMPARATOR
Intervention: Live demonstration for knee examination techniques
Number of subjects: 45
Study 21693058 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia teaching method for knee examination techniques
Number of subjects: 45
Study 21693058 — intervention group
Group type: COMPARATOR
Intervention: Live demonstration for ankle/foot examination techniques
Number of subjects: 45
Study 18584319 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutual support group
Number of subjects: 76
Study 18584319 — intervention group
Group type: COMPARATOR
Intervention: Standard psychiatric care
Number of subjects: 76
Study 16584285 — intervention group
Group type: COMPARATOR
Intervention: Tagamet 400mg tablet
Number of subjects: 12
Study 16584285 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% methacrylate copolymer cimetidine tablet
Number of subjects: 12
Study 16584285 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% methacrylate copolymer cimetidine tablet
Number of subjects: 12
Study 16584285 — intervention group
Group type: EXPERIMENTAL
Intervention: 26% methacrylate copolymer cimetidine tablet
Number of subjects: 12
Study 16584285 — intervention group
Group type: COMPARATOR
Intervention: Tagamet (300 mg/2 mL) intravenous injection
Number of subjects: 12
Study 12706917 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide 180 microg/kg bolus, 2 microg/kg/min infusion, and 180 microg/kg bolus 10 min later (180/2/180) plus half-dose TNK (0.27 mg/kg)
Number of subjects: 438
Study 12706917 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose TNK monotherapy (0.53 mg/kg)
Number of subjects: 438
Study 11097963 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (180 mg/day)
Number of subjects: 107
Study 11097963 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (38 mg/day)
Number of subjects: 107
Study 11097963 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 8866527 — intervention group
Group type: EXPERIMENTAL
Intervention: Shaping instruction for behavioral tests
Number of subjects: 74
Study 1473889 — intervention group
Group type: EXPERIMENTAL
Intervention: Ender nails
Number of subjects: 92
Study 1473889 — intervention group
Group type: COMPARATOR
Intervention: Sliding hip screw
Number of subjects: 92
Study 6385868 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (20 mg/kg/day)
Number of subjects: 33
Study 6385868 — intervention group
Group type: COMPARATOR
Intervention: Antacids (Maalox, 700 mmol (mEq)/1 X 73 m2/day)
Number of subjects: 33
Study 31371341 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 416
Study 31371341 — intervention group
Group type: COMPARATOR
Intervention: Everolimus
Number of subjects: 416
Study 31371341 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 416
Study 31371341 — intervention group
Group type: EXPERIMENTAL
Intervention: PD-L1 positive TC
Number of subjects: 416
Study 31371341 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined analysis of both trials
Number of subjects: 416
Study 27893563 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) - 12 weeks, 8 exercises, 3 sets of 8 to 12 repetitions at 75% 1-RM, 3 times per week
Number of subjects: 30
Study 27893563 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 30
Study 27893563 — intervention group
Group type: COMPARATOR
Intervention: Control - Usual care and maintenance of daily activities
Number of subjects: 30
Study 25963053 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-radiotherapy biopsy
Number of subjects: 303
Study 25963053 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive post-treatment biopsy
Number of subjects: 303
Study 23303466 — intervention group
Group type: EXPERIMENTAL
Intervention: WDYD intervention (web-based brief alcohol intervention)
Number of subjects: 913
Study 23303466 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 913
Study 21622815 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrally placed polyethylene screw and sheath implant (INTRAFIX)
Number of subjects: 113
Study 21622815 — intervention group
Group type: COMPARATOR
Intervention: Metal interference screw and staples (RCI)
Number of subjects: 113
Study 18452437 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcuminoids hydrogel patch with squid chitosan (1:1 ratio of curcuminoids microemulsion to polymer solution)
Number of subjects: 0
Study 18452437 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcuminoids hydrogel patch with squid chitosan
Number of subjects: 0
Study 18452437 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcuminoids hydrogel patch
Number of subjects: 0
Study 16490726 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of propacetamol 2 g and ketorolac 30 mg
Number of subjects: 16
Study 16490726 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg
Number of subjects: 16
Study 16490726 — intervention group
Group type: EXPERIMENTAL
Intervention: Propacetamol 2 g
Number of subjects: 16
Study 16490726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 12824718 — intervention group
Group type: EXPERIMENTAL
Intervention: Angina-free patients undergoing CABG
Number of subjects: 590
Study 12824718 — intervention group
Group type: COMPARATOR
Intervention: Patients with angina undergoing CABG
Number of subjects: 590